BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D, Vierling JM, Adams D, Alpini G, Banales JM, Beuers U, Björnsson E, Bowlus C, Carbone M, Chazouillères O, Dalekos G, De Gottardi A, Harada K, Hirschfield G, Invernizzi P, Jones D, Krawitt E, Lanzavecchia A, Lian ZX, Ma X, Manns M, Mavilio D, Quigley EM, Sallusto F, Shimoda S, Strazzabosco M, Swain M, Tanaka A, Trauner M, Tsuneyama K, Zigmond E, Gershwin ME. The challenges of primary biliary cholangitis: What is new and what needs to be done. J Autoimmun 2019;105:102328. [PMID: 31548157 DOI: 10.1016/j.jaut.2019.102328] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Huang B, Lyu Z, Qian Q, Chen Y, Zhang J, Li B, Li Y, Liang J, Liu Q, Li Y, Chen R, Lian M, Xiao X, Miao Q, Wang Q, Fang J, Lian Z, Li Y, Tang R, Helleday T, Gershwin ME, You Z, Ma X. NUDT1 promotes the accumulation and longevity of CD103+ TRM cells in primary biliary cholangitis. J Hepatol 2022:S0168-8278(22)00408-1. [PMID: 35753523 DOI: 10.1016/j.jhep.2022.06.014] [Reference Citation Analysis]
2 Bae UJ, Park BH, Cho MK, Bae EJ. Therapeutic Effect of Acer tegmentosum Maxim Twig Extract in Bile Duct Ligation-Induced Acute Cholestasis in Mice. J Med Food 2022;25:652-9. [PMID: 35708629 DOI: 10.1089/jmf.2022.K.0015] [Reference Citation Analysis]
3 Terziroli Beretta-Piccoli B, Mazzucchelli L, Taiana C, Mossi G, Usai C, Vergani D, Mieli-Vergani G. A patient with primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis variant syndrome. J Transl Autoimmun 2020;3:100033. [PMID: 32743518 DOI: 10.1016/j.jtauto.2019.100033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
4 Lachiondo-Ortega S, Mercado-Gómez M, Serrano-Maciá M, Lopitz-Otsoa F, Salas-Villalobos TB, Varela-Rey M, Delgado TC, Martínez-Chantar ML. Ubiquitin-Like Post-Translational Modifications (Ubl-PTMs): Small Peptides with Huge Impact in Liver Fibrosis. Cells 2019;8:E1575. [PMID: 31817258 DOI: 10.3390/cells8121575] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
5 Sarcognato S, Sacchi D, Grillo F, Cazzagon N, Fabris L, Cadamuro M, Cataldo I, Covelli C, Mangia A, Guido M. Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis. Pathologica 2021;113:170-84. [PMID: 34294935 DOI: 10.32074/1591-951X-245] [Reference Citation Analysis]
6 Sasaki M, Sato Y, Nakanuma Y. Increased p16INK4a-expressing senescent bile ductular cells are associated with inadequate response to ursodeoxycholic acid in primary biliary cholangitis. J Autoimmun 2020;107:102377. [PMID: 31812332 DOI: 10.1016/j.jaut.2019.102377] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Yu K, Li P, Xu T, Xu J, Wang K, Chai J, Zhao D, Liu Y, Wang Y, Ma J, Fan L, Guo S, Li Z, Li M, Wang Z. Decreased infiltration of CD4+ Th1 cells indicates a good response to ursodeoxycholic acid (UDCA) in primary biliary cholangitis. Pathol Res Pract 2021;217:153291. [PMID: 33249399 DOI: 10.1016/j.prp.2020.153291] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 van Beers JJBC, Koek GH, Damoiseaux JGMC. The Role of Autoantibodies in the Diagnosis of Autoimmune Liver Disease: Lessons Learned from Clinical Practice. J Appl Lab Med 2022;7:259-67. [PMID: 34996079 DOI: 10.1093/jalm/jfab099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Bauer A, Habior A. Concentration of Serum Matrix Metalloproteinase-3 in Patients With Primary Biliary Cholangitis. Front Immunol 2022;13:885229. [DOI: 10.3389/fimmu.2022.885229] [Reference Citation Analysis]
10 Jia H, Chen J, Zhang X, Bi K, Zhou H, Liu T, Xu J, Diao H. IL-17A produced by invariant natural killer T cells and CD3+ CD56+ αGalcer-CD1d tetramer- T cells promote liver fibrosis in patients with primary biliary cholangitis. J Leukoc Biol 2022. [PMID: 35730799 DOI: 10.1002/JLB.2A0622-586RRRR] [Reference Citation Analysis]
11 Wang L, Cao Z, Zhang L, Li J, Lv W. The Role of Gut Microbiota in Some Liver Diseases: From an Immunological Perspective. Front Immunol 2022;13:923599. [DOI: 10.3389/fimmu.2022.923599] [Reference Citation Analysis]
12 Cadamuro M, Girardi N, Gores GJ, Strazzabosco M, Fabris L. The Emerging Role of Macrophages in Chronic Cholangiopathies Featuring Biliary Fibrosis: An Attractive Therapeutic Target for Orphan Diseases. Front Med (Lausanne) 2020;7:115. [PMID: 32373615 DOI: 10.3389/fmed.2020.00115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Bauer A, Habior A, Wieszczy P, Gawel D. Analysis of Autoantibodies against Promyelocytic Leukemia Nuclear Body Components and Biochemical Parameters in Sera of Patients with Primary Biliary Cholangitis. Diagnostics (Basel) 2021;11:587. [PMID: 33805158 DOI: 10.3390/diagnostics11040587] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Li B, Zhang J, Chen Y, Wang Q, Yan L, Wang R, Wei Y, You Z, Li Y, Miao Q, Xiao X, Lian M, Chen W, Qiu D, Fang J, Gershwin ME, Tang R, Ma X. Alterations in microbiota and their metabolites are associated with beneficial effects of bile acid sequestrant on icteric primary biliary Cholangitis. Gut Microbes 2021;13:1946366. [PMID: 34437819 DOI: 10.1080/19490976.2021.1946366] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Prieto J, Banales JM, Medina JF. Primary biliary cholangitis: pathogenic mechanisms. Curr Opin Gastroenterol 2021;37:91-8. [PMID: 33332913 DOI: 10.1097/MOG.0000000000000703] [Reference Citation Analysis]
16 Xiang X, Yang X, Shen M, Huang C, Liu Y, Fan X, Yang L. Ursodeoxycholic Acid at 18-22 mg/kg/d Showed a Promising Capacity for Treating Refractory Primary Biliary Cholangitis. Can J Gastroenterol Hepatol 2021;2021:6691425. [PMID: 33542908 DOI: 10.1155/2021/6691425] [Reference Citation Analysis]
17 Jin W, Song S, Xu X, Wen C, Hu C. Role of gut microbiota in primary biliary cholangitis. Hepatobiliary & Pancreatic Diseases International 2022. [DOI: 10.1016/j.hbpd.2022.06.014] [Reference Citation Analysis]
18 Zeng X, Li S, Tang S, Li X, Zhang G, Li M, Zeng X, Hu C. Changes of Serum IgG Glycosylation Patterns in Primary Biliary Cholangitis Patients. Front Immunol 2021;12:669137. [PMID: 34248947 DOI: 10.3389/fimmu.2021.669137] [Reference Citation Analysis]
19 Kolev M, Horn MP, Semmo N, Nagler M. Rational development and application of biomarkers in the field of autoimmunity: A conceptual framework guiding clinicians and researchers. Journal of Translational Autoimmunity 2022. [DOI: 10.1016/j.jtauto.2022.100151] [Reference Citation Analysis]
20 Cheng C, Wang Z, Wang L, Zhao J, Wang Q, Tian X, Li M, Zeng X. Clinical characteristics and prognosis of concomitant systemic lupus erythematosus and primary biliary cholangitis. Clin Rheumatol 2021;40:1819-26. [PMID: 33067770 DOI: 10.1007/s10067-020-05457-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Bauer A, Habior A, Gawel D. Diagnostic and Clinical Value of Specific Autoantibodies against Kelch-like 12 Peptide and Nuclear Envelope Proteins in Patients with Primary Biliary Cholangitis. Biomedicines 2022;10:801. [DOI: 10.3390/biomedicines10040801] [Reference Citation Analysis]
22 Papamichalis PA, Zachou K, Papamichali RA, Ioannou M, Gatselis NK, Dalekos GN, Koukoulis GK. Promyelocytic Leukemia Antigen Expression: a Histological Marker for Primary Biliary Cholangitis Diagnosis? J Transl Int Med 2021;9:43-51. [PMID: 33850801 DOI: 10.2478/jtim-2021-0008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Trussoni CE, O'Hara SP, LaRusso NF. Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target. Semin Immunopathol 2022. [PMID: 35178659 DOI: 10.1007/s00281-022-00909-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
24 Woolbright BL. Inflammation: Cause or consequence of chronic cholestatic liver injury. Food Chem Toxicol. 2020;137:111133. [PMID: 31972189 DOI: 10.1016/j.fct.2020.111133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
25 Naguib R, Fayed A, Elkemary E, Naguib H. Serum Ghrelin Concentration in Patients With Primary Biliary Cirrhosis (PBC). Cureus 2021;13:e20288. [PMID: 34912653 DOI: 10.7759/cureus.20288] [Reference Citation Analysis]
26 Jawed R, Zhang M, Wang C, Yang SH, Jiang P, Wu Q, Li L, Chen W, Gershwin ME, Tian Y, Seldin MF, Ma X, Liu X, Lian ZX, Shi X. Replication study and meta-analysis indicate a suggestive association of RUNX3 locus with primary biliary cholangitis. Immunogenetics 2020;72:467-74. [PMID: 33284381 DOI: 10.1007/s00251-020-01192-4] [Reference Citation Analysis]
27 Trampert DC, van de Graaf SFJ, Jongejan A, Oude Elferink RPJ, Beuers U. Hepatobiliary acid-base homeostasis: Insights from analogous secretory epithelia. J Hepatol 2021;74:428-41. [PMID: 33342564 DOI: 10.1016/j.jhep.2020.10.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
28 Meister P, Steinke-Ramming C, Beste M, Lenzen H, Gerken G, Canbay A, Jochum C. CTLA-4 Expression Plays a Role in PSC and PBC Progression. Diseases 2020;8:E21. [PMID: 32545568 DOI: 10.3390/diseases8020021] [Reference Citation Analysis]
29 Huang C, Xing X, Xiang X, Fan X, Men R, Ye T, Yang L. MicroRNAs in autoimmune liver diseases: from diagnosis to potential therapeutic targets. Biomed Pharmacother 2020;130:110558. [PMID: 32781357 DOI: 10.1016/j.biopha.2020.110558] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Wang L, Cao ZM, Zhang LL, Dai XC, Liu ZJ, Zeng YX, Li XY, Wu QJ, Lv WL. Helicobacter Pylori and Autoimmune Diseases: Involving Multiple Systems. Front Immunol 2022;13:833424. [PMID: 35222423 DOI: 10.3389/fimmu.2022.833424] [Reference Citation Analysis]
31 Cai J, Wu J, Fang S, Liu S, Wang T, Li Y, Zou J, Shi R, Wang Z, Yang L, Ma Y. Cultured bear bile powder ameliorates acute liver injury in cholestatic mice via inhibition of hepatic inflammation and apoptosis. J Ethnopharmacol 2022;284:114829. [PMID: 34763041 DOI: 10.1016/j.jep.2021.114829] [Reference Citation Analysis]
32 Terziroli Beretta-Piccoli B, Stirnimann G, Mertens J, Semela D, Zen Y, Mazzucchelli L, Voreck A, Kolbus N, Merlo E, Di Bartolomeo C, Messina P, Cerny A, Costantini S, Vergani D, Mieli-Vergani G; Swiss PBC Cohort Study Group. Primary biliary cholangitis with normal alkaline phosphatase: A neglected clinical entity challenging current guidelines. J Autoimmun 2021;116:102578. [PMID: 33229138 DOI: 10.1016/j.jaut.2020.102578] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Rigopoulou EI, Dalekos GN. Current Trends and Characteristics of Hepatocellular Carcinoma in Patients with Autoimmune Liver Diseases. Cancers (Basel) 2021;13:1023. [PMID: 33804480 DOI: 10.3390/cancers13051023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
34 Xu J, Fu H, Yang Y, Yu H, Ai X, Lei Y, Bao W, Tang Y. Modulation of CXCR1 and CXCR3 expression on NK cells via Tim-3 in a murine model of primary biliary cholangitis. Mol Immunol 2021;135:342-50. [PMID: 33984607 DOI: 10.1016/j.molimm.2021.04.014] [Reference Citation Analysis]
35 Himoto T, Yamamoto S, Morimoto K, Tada S, Mimura S, Fujita K, Tani J, Morishita A, Masaki T. Clinical impact of antibodies to Sp100 on a bacterial infection in patients with primary biliary cholangitis. J Clin Lab Anal 2021;35:e24040. [PMID: 34623692 DOI: 10.1002/jcla.24040] [Reference Citation Analysis]